INNO MEDICINE
Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis.
INNO MEDICINE
Industry:
Biotechnology Market Research Therapeutics
Founded:
2016-01-01
Status:
Active
More informations about "Inno Medicine"
茵诺医药
Founded in 2016, Beijing Inno Medicine Co. Ltd. stands as a dynamic novel drug discovery, development and manufacturing company. As a national high-tech enterprise, Inno Medicine is committed to crafting precise and efficient diagnostic solutions and targeted medicine to …See details»
Inno Medicine - Crunchbase Company Profile & Funding
Organization. Inno Medicine . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. Inno Medicine …See details»
Key Milestones_About Inno_茵诺医药
Beijing Inno Medicine Co. Ltd. was incorporated. An in-house R&D team was established and awarded funds by NSFC and Beijing Science and Technology Commission. ... 2020. Inno Med …See details»
Inno Medicine - PitchBook
Inno Medicine General Information Description. Developer of cardiovascular medical technology designed for the precise treatment of atherosclerosis. The company's innovative medicines use nano-delivery platform technology to …See details»
创始人致辞-茵诺医药 - innovmedicine.com
在15年的心血管临床工作中，我时常要面对大量的动脉粥样硬化性心脑血管疾病的患者，无法精准高效治疗的困惑。面对病人数量逐年增多、病人群体逐渐年轻化，而治疗手段和药物的进步却始终不尽如人意的现状，我和我的团队开始了全 …See details»
Inno Medicine - Funding, Financials, Valuation & Investors
Inno Medicine has raised 1 round. This was a Venture - Series Unknown round raised on Jan 1, 2019 . Inno Medicine is funded by Beijing Capital Science and Technology Development Group .See details»
北京茵诺医药科技有限公司官网
北京茵诺医药科技有限公司成立于2016年，是一家年轻的国家级高新技术企业，也是一家充满活力的创新医药科技公司。我们针对患者医疗需求亚待满足的治疗领域，专注于创新精准高效的诊断和靶向药物的研发和转化落地，以惠及全球患 …See details»
Company Profile _About Inno_茵诺医药
Founded in 2016, Beijing Inno Medicine Co. Ltd. stands as a dynamic novel drug discovery, development and manufacturing company. As a national high-tech enterprise, Inno Medicine is committed to crafting precise and efficient …See details»
Beijing Inno Medicine Co., Ltd. - synapse.zhihuiya.com
Mar 8, 2025 了解Beijing Inno Medicine Co., Ltd. (北京茵诺医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验和1篇文献，疾病领域:免疫系统疾病，神经系统疾病，血液及淋巴系统疾病，肿瘤，内分泌与代谢 …See details»
Inno Medicine - Products, Competitors, Financials, Employees ...
Feb 19, 2025 Inno Medicine is a high-tech company focused on the pharmaceutical industry, specifically in the area of novel drug discovery, development, and manufacturing. Use the CB …See details»
Inno Medicine’s YN001 (Targeted Therapy of …
Ma Qian, Chairman and CEO of Inno Medicine, described the approval of clinical trials of YN001 as a milestone of Inno Medicine. The successful progress of the project reflects the company’s innovation, wisdom, perseverance, and …See details»
Inno Medicine - Crunchbase
Inno Medicine specializes in research on the pathogenesis of atherosclerosis. Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on …See details»
Beijing Inno Medicine Co., Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Beijing Inno Medicine Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, and 1 literature, Disease Domain:Immune System Diseases, Nervous …See details»
Founder's Message_About Inno_茵诺医药
With unwavering compassion and dedication, Inno Medicine places its trust in the power of science and strives to deliver meaningful benefits to patients. Our persistent efforts have …See details»
YN-002 (Inno Medicine) - Drug Targets, Indications, Patents
YN-002 (Inno Medicine), Initially developed by Beijing Inno Medicine Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Other Diseases ...See details»
投资机构_关于茵诺_北京茵诺医药科技有限公司官网
北京茵诺医药科技有限公司成立于2016年，是一家年轻的国家级高新技术企业，也是一家充满活力的创新医药科技公司。我们针对患者医疗需求亚待满足的治疗领域，专注于创新精准高效的诊 …See details»
YN-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
YN-001: a CD44 inhibitors, HMG-CoA reductase inhibitors Drug, Initially developed by Beijing Inno Medicine Co., Ltd., Now, its global highest R&D status is Phase 2, Mechanism: CD44 …See details»
Investors_About Inno_茵诺医药
Beijing Inno Medicine Co., Ltd. Address: Building 9, Area C, Xishan Creative Park, Haidian District, Beijing. Telephone number: +86 8259 9080See details»
The emerging era of structural nanomedicine - Nature
Apr 25, 2025 The lack of structural definition in nanomedicines limits therapeutic efficacy and complicates regulatory approval. Here, we emphasize that defining, designing and optimizing …See details»
Inno Medicine - Updates, News, Events, Signals & Triggers
Inno Medicine specializes in research on the pathogenesis of atherosclerosis. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»